Intellectual Property
Every innovation that improves lives, advances society, and drives our economy starts with an idea. Strong intellectual property rights—including patents, trademarks, and copyrights—protect and incentivize those ideas. When inventors, researchers, engineers, artists, and entrepreneurs have legal certainty that their work will be protected and rewarded, they can keep the transformative ideas coming. Intellectual property protections also shield consumers from dangerous fake and counterfeit goods, giving people assurances that products—from life-saving medicines to toys—are safe and authentic.
Latest
2024 International IP Index
The 12th edition of the U.S. Chamber’s International IP Index is a comprehensive assessment of the world’s intellectual property frameworks. It shows the power of smart policies to foster innovation, creativity, and economic growth and unlock opportunity.
Learn More
Become a part of the world’s largest business organization and network
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Our Work
The U.S. Chamber’s Global Innovation Policy Center champions innovation and creativity through intellectual property standards so businesses can save lives, solve problems, create jobs, advance growth, and enhance society. Our work to protect strong intellectual property rights begins in Washington, D.C., and extends to countries across the globe.
Events
- Small BusinessC-Suite to Main Street: The Power of Failure in Building Business SuccessThursday, April 0312:00 PM EDT - 12:30 PM EDTVirtualLearn More
- Intellectual PropertyGlobal IP SummitWednesday, April 0911:00 AM EDT - 04:00 PM EDTVirtualLearn More
- Intellectual Property2025 World IP Day Celebration and IP Index LaunchTuesday, April 1501:00 PM EDT - 04:30 PM EDTVirtualLearn More
Latest Content
Intellectual property enabled the discovery of lifesaving COVID-19 vaccines. Here’s why calls to waive IP rights would undermine medical innovation and our ability to respond to the next pandemic.
The U.S. Chamber of Commerce and U.S. Customs and Border Protection team up to launch the ‘Shop Smart’ campaign to protect consumers and businesses from counterfeit goods.
Worldwide trade in counterfeit and fake goods amounts to more than $500 billion each year. With the holiday shopping season about to kick off, here are some ways to avoid fake goods and shop smart.
Leaders from the public and private sectors explain how they are partnering with local communities to advance circular economies in the United States.
This Hill letter was sent to Members of the Senate Committee on Finance on Christopher S. Wilson’s nomination as the Chief Innovation and Intellectual Property Negotiator with the Office of the U.S. Trade Representative (USTR).
America is where innovation thrives, and cutting-edge medicine is no exception. Right now, scientists are conducting more than 140,000 clinical trials across all 50 states to explore the potential of the therapeutics, vaccines, diagnostics, and cures we need to fight disease—from coronavirus to cancer.
Issues surrounding intellectual property rights in the U.S. have a significant impact on the business community. Here’s what businesses need to know.
At the onset of the COVID-19 pandemic, Novo Nordisk recognized that patients, employees, and the community would be impacted in new and unique ways. The company focused on three key priorities:
Throughout the COVID-19 pandemic, countless people have found solace and even joy in the creative output of musicians, filmmakers, video-game creators, artists, and performers. While these creators’ individual innovations are unique, their dependence on copyright unites them. Copyright safeguards their creations’ value in the marketplace and protects them from malicious reproduction.
WASHINGTON, D.C. - U.S. Chamber of Commerce Executive Vice President and Chief Policy Officer Neil Bradley released the following statement today after the White House announcement on drug pricing:
